Sore Throat News and Research

RSS

Hot drinks help fight cold and flu

A hot drink may help reduce the symptoms of common colds and flu, according to new research by Cardiff University's Common Cold Centre.

10 Dec 2008

Merck Serono's Kuvan receives European marketing authorization

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission has granted marketing authorization for Kuvan(R) for the treatment of hyperphenylalaninemia (HPA) in phenylketonuria (PKU) or BH4 deficient patients.

10 Dec 2008

Common cold virus originated in birds

A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology.

20 Nov 2008

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.

10 Nov 2008

New hybrid technology for disease prevention

The earlier cancer is diagnosed, the better the chance of effecting a cure.

10 Nov 2008

Steroids aid recovery from pneumonia, UT Southwestern researchers say

Adding corticosteroids to traditional antimicrobial therapy might help people with pneumonia recover more quickly than with antibiotics alone, UT Southwestern Medical Center scientists have found.

14 Oct 2008

Deadly virus scrumpox a threat to rugby players wrestlers

Rugby players and wrestlers may be at risk of a potentially serious skin disease called "scrumpox".

29 Sep 2008

Scrumpox - deadly rugby virus spreads in sumo wrestlers

Rugby players may get more than just the ball out of a scrum - herpes virus can cause a skin disease called "scrumpox" and it spreads through physical contact. Researchers have studied the spread of the disease among sumo wrestlers in Japan and have discovered that a new strain of the virus could be even more pathogenic, according to an article published in the October issue of the Journal of General Virology.

28 Sep 2008

Emergency measures employed to stop measles epidemic

Emergency measures are being adopted in Britain to tackle the escalating numbers of new measles cases.

22 May 2008

Study explains why steroid therapy for sinusitis and asthma loses its punch over time

Scientists at Johns Hopkins have outlined a new path for potential therapies to combat inflammation associated with sinusitis and asthma based on a new understanding of the body's earliest immune response in the nose and sinus cavities.

29 Apr 2008

Three bitten by rabid dog in Britain

A dog imported into Britain from Sri Lanka has died of rabies but not before it had bitten three people.

28 Apr 2008

Human vaccine for Ebola in the pipeline

The deadly Ebola virus is in the news again but this time there is the promise of a vaccine for the deadly disease.

1 Apr 2008

Ebola virus vaccines for humans

One of the world's deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian researchers, who have successfully tested several Ebola vaccines in primates and are now looking to adapt them for human use.

31 Mar 2008

Mysterious fevers of unknown origin: Could surgery be a cure?

A child spikes a high fever, sometimes as high as 104 or 105 degrees, and sometimes causing seizures.

31 Mar 2008

Probiotics help keep elite athletes fit and well

According to the latest Australian research the immune system of long-distance runners was enhanced by probiotics - dietary supplements containing potentially beneficial bacteria or yeasts.

13 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008